Continuous vs Intermittent β-Lactam Antibiotic Infusions in Patients With Sepsis

Joel M. Dulhunty, MD, PhD, Royal Brisbane and Women’s Hospital, and Jason A. Roberts, BPharm, PhD, University of Queensland Centre for Clinical Research, join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the BLING trial that assessed continuous vs intermittent β-lactam antibiotic infusions in patients with sepsis or septic shock.

Related Content:

• Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis
• Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock